BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29580235)

  • 1. Performance of in silico prediction tools for the classification of rare BRCA1/2 missense variants in clinical diagnostics.
    Ernst C; Hahnen E; Engel C; Nothnagel M; Weber J; Schmutzler RK; Hauke J
    BMC Med Genomics; 2018 Mar; 11(1):35. PubMed ID: 29580235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of blind predictions of the clinical significance of BRCA1 and BRCA2 variants.
    Cline MS; Babbi G; Bonache S; Cao Y; Casadio R; de la Cruz X; Díez O; Gutiérrez-Enríquez S; Katsonis P; Lai C; Lichtarge O; Martelli PL; Mishne G; Moles-Fernández A; Montalban G; Mooney SD; O'Conner R; Ootes L; Özkan S; Padilla N; Pagel KA; Pejaver V; Radivojac P; Riera C; Savojardo C; Shen Y; Sun Y; Topper S; Parsons MT; Spurdle AB; Goldgar DE;
    Hum Mutat; 2019 Sep; 40(9):1546-1556. PubMed ID: 31294896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved, ACMG-compliant, in silico prediction of pathogenicity for missense substitutions encoded by TP53 variants.
    Fortuno C; James PA; Young EL; Feng B; Olivier M; Pesaran T; Tavtigian SV; Spurdle AB
    Hum Mutat; 2018 Aug; 39(8):1061-1069. PubMed ID: 29775997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a New, Endophenotype-Based Strategy for Pathogenicity Prediction in BRCA1 and BRCA2: In Silico Modeling of the Outcome of HDR/SGE Assays for Missense Variants.
    Özkan S; Padilla N; de la Cruz X
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large scale multifactorial likelihood quantitative analysis of BRCA1 and BRCA2 variants: An ENIGMA resource to support clinical variant classification.
    Parsons MT; Tudini E; Li H; Hahnen E; Wappenschmidt B; Feliubadaló L; Aalfs CM; Agata S; Aittomäki K; Alducci E; Alonso-Cerezo MC; Arnold N; Auber B; Austin R; Azzollini J; Balmaña J; Barbieri E; Bartram CR; Blanco A; Blümcke B; Bonache S; Bonanni B; Borg Å; Bortesi B; Brunet J; Bruzzone C; Bucksch K; Cagnoli G; Caldés T; Caliebe A; Caligo MA; Calvello M; Capone GL; Caputo SM; Carnevali I; Carrasco E; Caux-Moncoutier V; Cavalli P; Cini G; Clarke EM; Concolino P; Cops EJ; Cortesi L; Couch FJ; Darder E; de la Hoya M; Dean M; Debatin I; Del Valle J; Delnatte C; Derive N; Diez O; Ditsch N; Domchek SM; Dutrannoy V; Eccles DM; Ehrencrona H; Enders U; Evans DG; Farra C; Faust U; Felbor U; Feroce I; Fine M; Foulkes WD; Galvao HCR; Gambino G; Gehrig A; Gensini F; Gerdes AM; Germani A; Giesecke J; Gismondi V; Gómez C; Gómez Garcia EB; González S; Grau E; Grill S; Gross E; Guerrieri-Gonzaga A; Guillaud-Bataille M; Gutiérrez-Enríquez S; Haaf T; Hackmann K; Hansen TVO; Harris M; Hauke J; Heinrich T; Hellebrand H; Herold KN; Honisch E; Horvath J; Houdayer C; Hübbel V; Iglesias S; Izquierdo A; James PA; Janssen LAM; Jeschke U; Kaulfuß S; Keupp K; Kiechle M; Kölbl A; Krieger S; Kruse TA; Kvist A; Lalloo F; Larsen M; Lattimore VL; Lautrup C; Ledig S; Leinert E; Lewis AL; Lim J; Loeffler M; López-Fernández A; Lucci-Cordisco E; Maass N; Manoukian S; Marabelli M; Matricardi L; Meindl A; Michelli RD; Moghadasi S; Moles-Fernández A; Montagna M; Montalban G; Monteiro AN; Montes E; Mori L; Moserle L; Müller CR; Mundhenke C; Naldi N; Nathanson KL; Navarro M; Nevanlinna H; Nichols CB; Niederacher D; Nielsen HR; Ong KR; Pachter N; Palmero EI; Papi L; Pedersen IS; Peissel B; Perez-Segura P; Pfeifer K; Pineda M; Pohl-Rescigno E; Poplawski NK; Porfirio B; Quante AS; Ramser J; Reis RM; Revillion F; Rhiem K; Riboli B; Ritter J; Rivera D; Rofes P; Rump A; Salinas M; Sánchez de Abajo AM; Schmidt G; Schoenwiese U; Seggewiß J; Solanes A; Steinemann D; Stiller M; Stoppa-Lyonnet D; Sullivan KJ; Susman R; Sutter C; Tavtigian SV; Teo SH; Teulé A; Thomassen M; Tibiletti MG; Tischkowitz M; Tognazzo S; Toland AE; Tornero E; Törngren T; Torres-Esquius S; Toss A; Trainer AH; Tucker KM; van Asperen CJ; van Mackelenbergh MT; Varesco L; Vargas-Parra G; Varon R; Vega A; Velasco Á; Vesper AS; Viel A; Vreeswijk MPG; Wagner SA; Waha A; Walker LC; Walters RJ; Wang-Gohrke S; Weber BHF; Weichert W; Wieland K; Wiesmüller L; Witzel I; Wöckel A; Woodward ER; Zachariae S; Zampiga V; Zeder-Göß C; ; Lázaro C; De Nicolo A; Radice P; Engel C; Schmutzler RK; Goldgar DE; Spurdle AB
    Hum Mutat; 2019 Sep; 40(9):1557-1578. PubMed ID: 31131967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral.
    Tavtigian SV; Deffenbaugh AM; Yin L; Judkins T; Scholl T; Samollow PB; de Silva D; Zharkikh A; Thomas A
    J Med Genet; 2006 Apr; 43(4):295-305. PubMed ID: 16014699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional evaluation of BRCA1/2 variants of unknown significance with homologous recombination assay and integrative in silico prediction model.
    Guo Q; Ji S; Takeuchi K; Urasaki W; Suzuki A; Iwasaki Y; Saito H; Xu Z; Arai M; Nakamura S; Momozawa Y; Chiba N; Miki Y; Matsuura M; Sunada S
    J Hum Genet; 2023 Dec; 68(12):849-857. PubMed ID: 37731132
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Khan MA; Varma AK
    J Biomol Struct Dyn; 2023 Nov; 41(19):9879-9889. PubMed ID: 36404616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1 Circos: a visualisation resource for functional analysis of missense variants.
    Jhuraney A; Velkova A; Johnson RC; Kessing B; Carvalho RS; Whiley P; Spurdle AB; Vreeswijk MP; Caputo SM; Millot GA; Vega A; Coquelle N; Galli A; Eccles D; Blok MJ; Pal T; van der Luijt RB; Santamariña Pena M; Neuhausen SL; Donenberg T; Machackova E; Thomas S; Vallée M; Couch FJ; Tavtigian SV; Glover JN; Carvalho MA; Brody LC; Sharan SK; Monteiro AN;
    J Med Genet; 2015 Apr; 52(4):224-30. PubMed ID: 25643705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed.
    Hicks S; Wheeler DA; Plon SE; Kimmel M
    Hum Mutat; 2011 Jun; 32(6):661-8. PubMed ID: 21480434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive evaluation and efficient classification of BRCA1 RING domain missense substitutions.
    Clark KA; Paquette A; Tao K; Bell R; Boyle JL; Rosenthal J; Snow AK; Stark AW; Thompson BA; Unger J; Gertz J; Varley KE; Boucher KM; Goldgar DE; Foulkes WD; Thomas A; Tavtigian SV
    Am J Hum Genet; 2022 Jun; 109(6):1153-1174. PubMed ID: 35659930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel gene-specific Bayesian Gaussian mixture model to predict the missense variants pathogenicity of Sanfilippo syndrome.
    Mohammed EEA; Fayez AG; Abdelfattah NM; Fateen E
    Sci Rep; 2024 May; 14(1):12148. PubMed ID: 38802532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward classification of BRCA1 missense variants using a biophysical approach.
    Rowling PJ; Cook R; Itzhaki LS
    J Biol Chem; 2010 Jun; 285(26):20080-7. PubMed ID: 20378548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of the functional impact of missense variants in BRCA1 and BRCA2 with BRCA-ML.
    Hart SN; Polley EC; Shimelis H; Yadav S; Couch FJ
    NPJ Breast Cancer; 2020; 6():13. PubMed ID: 32377563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant effect predictions capture some aspects of deep mutational scanning experiments.
    Reeb J; Wirth T; Rost B
    BMC Bioinformatics; 2020 Mar; 21(1):107. PubMed ID: 32183714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRCA2 Polymorphisms and Breast Cancer Susceptibility: a Multi-Tools Bioinformatics Approach.
    Jan H; Khan NU; Al-Qaaneh AM; Tasleem M; Almutairi MH; Ali I
    Cell Physiol Biochem; 2024 Mar; 58(2):128-143. PubMed ID: 38623065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multigene testing of moderate-risk genes: be mindful of the missense.
    Young EL; Feng BJ; Stark AW; Damiola F; Durand G; Forey N; Francy TC; Gammon A; Kohlmann WK; Kaphingst KA; McKay-Chopin S; Nguyen-Dumont T; Oliver J; Paquette AM; Pertesi M; Robinot N; Rosenthal JS; Vallee M; Voegele C; Hopper JL; Southey MC; Andrulis IL; John EM; Hashibe M; Gertz J; ; Le Calvez-Kelm F; Lesueur F; Goldgar DE; Tavtigian SV
    J Med Genet; 2016 Jun; 53(6):366-76. PubMed ID: 26787654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A computational method to classify variants of uncertain significance using functional assay data with application to BRCA1.
    Iversen ES; Couch FJ; Goldgar DE; Tavtigian SV; Monteiro AN
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1078-88. PubMed ID: 21447777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Set of in Silico Tools to Support the Interpretation of ATM Missense Variants Using Graphical Analysis.
    Porras LM; Padilla N; Moles-Fernández A; Feliubadaló L; Santamariña-Pena M; Sánchez AT; López-Novo A; Blanco A; de la Hoya M; Molina IJ; Osorio A; Pineda M; Rueda D; Ruiz-Ponte C; Vega A; Lázaro C; Díez O; Gutiérrez-Enríquez S; de la Cruz X
    J Mol Diagn; 2024 Jan; 26(1):17-28. PubMed ID: 37865290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the clinical relevance of unclassified variants in DNA repair genes: a focus on
    Boujemaa M; Nouira F; Jandoubi N; Mejri N; Bouaziz H; Charfeddine C; Ben Nasr S; Labidi S; El Benna H; Berrazega Y; Rachdi H; Daoud N; Benna F; Haddaoui A; Abdelhak S; Samir Boubaker M; Boussen H; Hamdi Y
    Front Genet; 2024; 15():1327894. PubMed ID: 38313678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.